The Centers for Disease Control and Prevention is still seeking public comments on how Americans with chronic pain are successfully treating their symptoms. The deadline to submit comments to the agency is Tuesday, June 16, 2020.
“Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.”
Data published today in the weekly publication of the US Centers for Disease Control and Prevention provides further evidence that the presence of vitamin E acetate (oil) in illicit market, e-liquid vape products is likely associated with EVALI (e-cigarette or vaping product use-associated lung injury).
Updated data provided today by the US Centers for Disease Control reports over 800 cases of acute respiratory distress linked to the use of portable vapor cartridges used to consume certain e-liquids. Of the products tested thus far by the US Food and Drug Administration, about half have identified the presence of Vitamin E acetate.
The US Centers for Disease Control has now identified over 450 cases of respiratory distress that may be associated with the use of disposable vapor cartridges used to consume certain e-liquids.
Prohibitionists often claim that legalizing and regulating marijuana will increase youth access to the plant. But newly released federal data says just the opposite.
The passage of statewide laws regulating the consumption of cannabis by adults and/or qualified patients is not associated with increased rates of teen marijuana use, according to a statistical analysis of results from the Centers for Disease Control and Prevention’s 2015 Youth Risk Behavior Survey.